# NIO Inc.: Form 20-F for the period ended Dec 31, 2022

- Company: [NIO Inc.](/companies/nio.md) (CIK 1736541)
- Form: 20-F
- Filed: 2023-04-28
- Accepted by EDGAR: Apr 28, 2023, 10:32 ET
- Period: 2022-12-31
- Accession: 0001104659-23-051990
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736541/000110465923051990/nio-20221231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736541/000110465923051990/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | $7.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2022-01-01 to 2022-12-31 | $6.40bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2022-01-01 to 2022-12-31 | $745.8m | us-gaap:GrossProfit |
| Research and development | 12 months, 2022-01-01 to 2022-12-31 | $1.57bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2022-01-01 to 2022-12-31 | $1.53bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | −$2.27bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2022-01-01 to 2022-12-31 | $48.3m | us-gaap:InterestExpense |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | $8.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | −$2.09bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | −$1.29 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | −$1.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2022-01-01 to 2022-12-31 | 1,636,999,280 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | −$560.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $1.01bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2022-12-31 | $2.88bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-12-31 | $8.58bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | $13.96bn | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | $6.65bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-12-31 | $9.95bn | us-gaap:Liabilities |
| Long-term debt | at 2022-12-31 | $1.58bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-12-31 | $179.5m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2022-12-31 | $585.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2022-12-31 | $3.46bn | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736541/000110465923051990/nio-20221231x20f.htm

Filed Apr 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-051990. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.